The Gross Law Firm issues the following notice to shareholders ofLantheus Holdings, Inc. (NASDAQ: LNTH). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of LNTH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Lantheus Loss […]

The Gross Law Firm issues the following notice to shareholders ofUnicycive Therapeutics, Inc. (NASDAQ: UNCY). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of UNCY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Unicycive Therapeutics,

The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of SVRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Savara Inc.

Anchin, a leading accounting and advisory firm based in New York, is proud to announce a series of prestigious recognitions that affirm its continued commitment to excellence, innovation, and employee satisfaction. Over the recent months, Anchin has once again proven itself to be a firm of choice for both clients and professionals. https://mma.prnewswire.com/media/1874473/Anchin_2022_Logo_v1.jpg Among the

Highlights Transaction's Flawed Process, Deficient Structure and Inadequate Price Urges Shareholders to Vote AGAINST the Proposed Transaction Two Seas Capital LP (“Two Seas” or “we”), an alternative investment management firm and the largest active shareholder of Core Scientific, Inc. (“Core Scientific” or the “Company”) (NASDAQ: CORZ), today released an investor presentation, which was filed with

AudioCodes (NASDAQ: AUDC), a leading provider of voice, contact center and conversational AI applications and services for enterprises, today announced that it will release financial results for its Third Quarter 2025on Tuesday, November 04, 2025, before the market open on NASDAQ, reflecting the quarterly period ended September 30, 2025. AudioCodes' financial results will be released

— Enhanced Toyota Audio Multimedia experience will launch with 2026 RAV4 — First integration of AT&T 5G network connectivity — Intuitive, smartphone-like design offers customizable widgets on the head unit home screen — New embedded Voice Assistant functions enable faster responses to “Hey Toyota” prompts — Enhanced entertainment with introduction ofSiriusXM with 360L® and newly

Oceania Cruises®, the world's leading culinary- and destination-focused luxury cruise line, today announced Food & Wine's acclaimed Best New Chefs franchise will serve as the official godparent of the line's newest ship, Oceania Allura, which debuted in July 2025 and will be christened in Miami on November 13. This historic collaboration marks the first time

iRegene Therapeutics Co., Ltd. (“iRegene” or the “Company”) is recognized as a biotechnology company pioneering chemically induced allogeneic cell therapy. iRegene's lead product, NouvNeu001, is the 1st iPSC therapy to receive IND approval from both the NMPA and the FDA to treat Parkinson's disease (PD). Recently, NouvNeu001 Phase I clinical data were presented at the

— RESORB Study Marks Major Step Toward U.S. Regulatory Approval and Global Commercialization NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, today announced the enrollment of the first patient in its U.S. pivotal clinical trial evaluating Nexsphere-F™, the company's novel fast resorbable microsphere for musculoskeletal pain embolization. This milestone